Please login to the form below

Not currently logged in
Email:
Password:

The LionsDen Communications Award for Excellence in Payer and Policy Maker Engagement


The LionsDen Communications Award for Excellence in Payer and Policy Maker Engagement

This award recognises excellence in programmes that engage one or more key payer/stakeholder group(s) (national, regional or European) to develop and broaden debate with clinical, governmental, public and/or other stakeholders to achieve policy change that will lead to improvements in:

  • Health outcomes - delivered by challenging inequality of health outcomes, clinical care or access to medicines or services
  • Clinical practice 
  • Standards of treatment
  • Planning, coordination or delivery of services. 

Work carried out during the two-year period between January 2011 and December 2012 will be eligible.

Submissions entered previously must demonstrate how the programme has been further developed during the additional time period.

Entries are invited from:

  • Charities
  • Patient or professional associations/bodies
  • Pharmaceutical companies
  • Healthcare agencies/consultancies
  • Trade associations.

Judging criteria:

  • Analysis of the problem and evidence of customer insight
  • Quality of the strategy/tactics employed to achieve key objectives
  • Evidence of change effected through communication with national or European payers/policy makers 
  • Evidence of support from a range of interested stakeholders, e.g. healthcare professionals and patient representatives
  • Effectiveness - evidence of changed behaviours and enhanced health outcomes
  • Stakeholder/customer feedback


Sponsors

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...
PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...

Infographics